Why the study?
The interdependence between type 2 diabetes mellitus, atrial fibrillation, and cognitive decline or dementia remains a debated topic.
Does the presence of type 2 diabetes mellitus and/or atrial fibrillation increase the severity of cognitive decline and depression in patients with very high cardiovascular risk?
Does the presence of type 2 diabetes mellitus and/or atrial fibrillation increase the severity of cognitive decline and depression in patients with very high cardiovascular risk?
Patients with both type 2 diabetes and atrial fibrillation experience more severe cognitive decline and depression compared to those with only one condition or controls, with risk correlating with cardiovascular risk scores and depression.
May support cognitive monitoring in DM-2/AF with high SCORE2; leaves open prospective validation before practice change.
Background: The interdependence between type 2 diabetes mellitus (DM-2), atrial fibrillation (AF), and cognitive decline (CD)/dementia is a debated topic. In this study, we highlighted the influence of DM-2 and FA individually and in association on the severity of CD/dementia. Methods: This study comprises 248 patients with very high cardiovascular risk (VHCVR) according to Systematic Coronary Risk Evaluation (SCORE2), of whom 184 had DM-2 and/or AF, and 64 were age-matched controls (without DM-2/AF), admitted to the Municipal Hospital Timisoara. Results: Mini-Mental-State-Examination (MMSE), Montreal Cognitive Assessment (MoCA), Activities of Daily Living Score (ADL), and Instrumental Activities of Daily Living Score (IADL) were significantly decreased, and Geriatric Depression Scale (GDS-15) increased in patients with DM-2 and AF in comparison to controls (p < 0.05), with the subjects with DM-2 and AF having more severe CD compared to those with only one of these two pathologies. The logistic regression model showed that the risk of CD (MMSE < 27) or dementia (MMSE < 24) increased significantly in patients with DM-2 and/or AF depending on the SCORE2 values, ADL, and GDS-15. In DM-2 and/or AF patients, an increase of 1% in SCORE2 was associated with an elevation of 2.40% in the odds of CD and of 4.30% of dementia. In these patients, depression (GDS score) increased the risk of CD by 36.3%, and if ADL improved, the risk of CD decreased by 44.0%. Conclusions: Our findings suggest a direct association between CD, DM-2, and AF with SCORE2, cognitive parameters, ADL, and depression. In patients with DM-2 and/or AF, it is important to identify subclinical CD to prevent the evolution to dementia.
No takes yet. Share an insight, caveat, or question.
Militaru et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: